These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3590103)

  • 1. Thrombelastography of blood from subjects with chronic renal failure.
    Holloway DS; Vagher JP; Caprini JA; Simon NM; Mockros LF
    Thromb Res; 1987 Mar; 45(6):817-25. PubMed ID: 3590103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skin bleeding time for the evaluation of uremic platelet dysfunction and effect of dialysis.
    Soyoral YU; Demir C; Begenik H; Esen R; Kucukoglu ME; Aldemir MN; Demirkiran D; Erkoc R
    Clin Appl Thromb Hemost; 2012; 18(2):185-8. PubMed ID: 22327827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dialyzable factors from uremic serum increase 125I-fibrinogen binding by normal blood platelets.
    Komarnicki M; Krupa D; Kaźmierczak M; Drobnik D; Zozulińska M
    Nephron; 1990; 55(4):372-4. PubMed ID: 2202919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma and platelet von Willebrand factor defects in uremia.
    Gralnick HR; McKeown LP; Williams SB; Shafer BC; Pierce L
    Am J Med; 1988 Dec; 85(6):806-10. PubMed ID: 3264111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelets and platelet function in patients with chronic uremia on maintenance hemodialysis.
    Jørgensen KA; Ingeberg S
    Nephron; 1979; 23(5):233-6. PubMed ID: 481658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The so-called "onion-like shape thromboelastogram" in dialyzed uraemic patients.
    Suchecki T
    Thromb Diath Haemorrh; 1974 Jun; 31(3):513-6. PubMed ID: 4424222
    [No Abstract]   [Full Text] [Related]  

  • 7. Normalization of hematocrit in a uremic patient receiving hemodialysis: role of erythropoietin.
    Chandra M; Garcia JF; Miller ME; Waldbaum RS; Bluestone PA; McVicar M
    J Pediatr; 1983 Jul; 103(1):80-3. PubMed ID: 6345743
    [No Abstract]   [Full Text] [Related]  

  • 8. Platelet function testing in uraemic patients.
    Ho SJ; Gemmell R; Brighton TA
    Hematology; 2008 Feb; 13(1):49-58. PubMed ID: 18534067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced blood bcl-2 protein concentration in patients on hemodialysis.
    Buemi M; Allegra A; Corica F; Ruello M; Di Pasquale G; Aloisi C; Giaccobe MS; Romeo A; Frisina N
    Blood Purif; 1998; 16(6):312-6. PubMed ID: 10343077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of recombinant human erythropoietin on hemostatic status in chronic uremic patients.
    Tsao CJ; Kao RH; Cheng TY; Huang CC; Chang SL; Lee FN
    Int J Hematol; 1992 Apr; 55(2):197-203. PubMed ID: 1511168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formation, consistency and degradation of artificial thrombi in severe renal failure. Effect of ABO blood groups.
    Dintenfass L; Stewart JH
    Thromb Diath Haemorrh; 1968 Nov; 20(1):267-84. PubMed ID: 5708897
    [No Abstract]   [Full Text] [Related]  

  • 12. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated fibrinogen fragment levels in uremic plasma inhibit platelet function and expression of glycoprotein IIb-IIIa.
    Thekkedath UR; Chirananthavat T; Leypoldt JK; Cheung AK; Mohammad SF
    Am J Hematol; 2006 Dec; 81(12):915-26. PubMed ID: 16917914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "In vitro" inhibition of platelet aggregation by uremic middle molecules.
    Gallice P; Fournier N; Crevat A; Saingra S; Frayssinet R; Murisasco A; Sicardi F
    Biomedicine; 1980; 33(6):185-8. PubMed ID: 7213919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of platelet surface receptor abnormalities in the bleeding and thrombotic diathesis of uremic patients on hemodialysis and peritoneal dialysis.
    Salvati F; Liani M
    Int J Artif Organs; 2001 Mar; 24(3):131-5. PubMed ID: 11314805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perioperative hypercoagulability in uremic patients: a viscoelastic study.
    Pivalizza EG; Abramson DC; Harvey A
    J Clin Anesth; 1997 Sep; 9(6):442-5. PubMed ID: 9278828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyridoxal 5'-phosphate deficiency in uremic undialyzed, hemodialyzed, and non-uremic kidney transplant patients.
    Lacour B; Parry C; Drüeke T; Touam M; Kreis H; Bailly M; Durand D
    Clin Chim Acta; 1983 Jan; 127(2):205-15. PubMed ID: 6337752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deranged concentrations of water-soluble vitamins in the blood of undialyzed and dialyzed patients with chronic renal failure.
    Marumo F; Kamata K; Okubo M
    Int J Artif Organs; 1986 Jan; 9(1):17-24. PubMed ID: 3957450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of hemodialysis on platelet function in end-stage renal disease Egyptian patients using in vitro closure time test (PFA-100 analyzer).
    Mekawy MA; Habashy DM; Abd El-Mohsen WA
    Platelets; 2015; 26(5):443-7. PubMed ID: 24955720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of sulfinpyrazone upon antithrombin III and platelet factor 4 in chronic renal failure.
    Bern MM; Green J
    Thromb Res; 1982 Aug; 27(4):457-65. PubMed ID: 7147215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.